期刊文献+

血管内皮生长因子在膀胱癌中的研究进展 被引量:13

Research progress of vascular endothelial growth factor in bladder cancer
下载PDF
导出
摘要 血管内皮生长因子(VEGF)是调控血管和淋巴管形成的关键因子,其在膀胱肿瘤增殖、侵袭和转移的过程中发挥着重要作用,大量研究证实VEGF表达水平与膀胱癌患者的预后密切相关,膀胱癌的VEGF靶向治疗已成为当前的研究热点。文章就VEGF促肿瘤机制、VEGF与膀胱癌发生发展的相关性以及VEGF膀胱癌靶向治疗的相关研究现状进行综述。 Vascular endothelial growth factor(VEGF)is known as the most efficient promote blood vessel growth factor.Numerical novel researches has confirmed that it plays a key role in bladder cancer proliferation,invasion and metastasis.The increasing clinical trials have aimed at targeting VEGF pathway.The encouraging outcomes provide new feasibility on bladder tumor treatment.Theis review conducted to discuss the tumor promoting mechanisms,bladder cancer progression relevance and bladder tumor target therapy of VEGF.
作者 保欣 王海峰 王剑松 BAO Xin;WANG Hai-feng;WANG Jian-song(Department of Urology,the Second Affiliated Hospital of Kunming Medical University,Kunming 650101,Yunnan,China)
出处 《医学研究生学报》 CAS 北大核心 2018年第9期986-990,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金(81660423)
关键词 血管内皮生长因子 膀胱肿瘤 靶向治疗 vascular endothelial growth factor bladder cancer targeted therapies
  • 相关文献

参考文献4

二级参考文献62

  • 1葛京平,魏武,魏威,张征宇,高建平,马驰原.survivin在膀胱癌中的表达及其临床意义[J].医学研究生学报,2006,19(8):716-718. 被引量:9
  • 2袁源智,袁非,黎蕾,汪洋,童蓓燕.基质细胞衍生因子-1在Wistar大鼠视网膜上的生理性表达[J].眼科研究,2007,25(7):518-521. 被引量:8
  • 3Lee EM, Ruth MP, Cristina P, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study : a case-control study [ J]. Lancet Oncol,2008, 9(4) : 359-366.
  • 4Jorunn L, Vendil V, Jens GH, et al. Immunohistoehemical markers in urinary bladder carcinomas from paraf? n-embedded archival tissue after storage for 5-70 years[ J]. BJU Int,2007,99 (5) :1013-1019.
  • 5Gregor M. Clinical Pathology of Urologic Tumors [ M]. London: Informa ,2007:57-58.
  • 6Antonio SS, Juan GL, Jose MG, et ol. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: A long-term study[J]. Urol Oncol,2008,26(6) : 620-626.
  • 7Fu TY, Tu MS, Tseng HH, et al. Overexpression of p27kipl in urinary bladder urothelial carcinoma [ J]. Int J Urol, 2007 , 14 (12) :1084-1087.
  • 8Ye Y, Yang H, Grossman HB, et al. Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Bladder Cancer [ J]. Cancer , 2008 ,112 ( 11 ) :2467-2474.
  • 9Kesavan E, Edmund C, Thomas PT, et al. Predictive Value of p53 and pRb Expression in Superficial Bladder Cancer Patients Treated With BCG and Interferon-alpha[ J]. Cancer, 2007 ,109 (6) :1097-1105.
  • 10Lopez-Behran A, Requena A J, Luque R J, et al. Cyclin D3 expression in primary Ta/T1 bladder cancer[ J]. J Pathol,2006, 209(1) : 106-113.

共引文献48

同被引文献98

引证文献13

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部